[{"id":"9e1d2e6b-9b69-4c07-8e37-79f5ee9bfe43","acronym":"","url":"https://clinicaltrials.gov/study/NCT05985083","created_at":"2023-08-14T16:10:04.733Z","updated_at":"2024-07-02T16:35:34.766Z","phase":"Phase 1","brief_title":"A Study Of IMM47 In Subjects With Advanced Solid Tumors","source_id_and_acronym":"NCT05985083","lead_sponsor":"ImmuneOnco Biopharmaceuticals (Shanghai) Inc.","biomarkers":" PD-L1 • CD24","pipe":" | ","alterations":" CD24 expression","tags":["PD-L1 • CD24"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e CD24 expression"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e IMM47"],"overall_status":"Recruiting","enrollment":" Enrollment 48","initiation":"Initiation: 08/18/2023","start_date":" 08/18/2023","primary_txt":" Primary completion: 12/26/2024","primary_completion_date":" 12/26/2024","study_txt":" Completion: 01/23/2025","study_completion_date":" 01/23/2025","last_update_posted":"2023-10-04"},{"id":"8fa47276-c7df-4988-ba8b-309aa603bcbf","acronym":"","url":"https://clinicaltrials.gov/study/NCT04907422","created_at":"2021-05-28T13:52:47.986Z","updated_at":"2024-07-02T16:36:25.035Z","phase":"","brief_title":"Diagnostic and Prognostic Accuracy of Gold Nanoparticles in Salivary Gland Tumours","source_id_and_acronym":"NCT04907422","lead_sponsor":"Amina Fouad Farag","biomarkers":" CD24","pipe":" | ","alterations":" CD24 expression","tags":["CD24"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e CD24 expression"],"overall_status":"Completed","enrollment":" Enrollment 60","initiation":"Initiation: 08/06/2018","start_date":" 08/06/2018","primary_txt":" Primary completion: 02/03/2019","primary_completion_date":" 02/03/2019","study_txt":" Completion: 02/03/2021","study_completion_date":" 02/03/2021","last_update_posted":"2021-09-01"}]